A recent systematic review and meta-analysis of 20 randomized controlled trials (RCTs) suggests that carnitine supplementation may yield measurable improvements in specific quality of life (QoL) domains. The study, which examined data from 21 distinct study arms and 1878 participants, identified significant enhancements in general health, the management of bodily pain, reported vitality, and social functioning. While these findings offer potential insights for clinical and public health interventions, the researchers emphasized that the impact of carnitine on quality of life remains a complex issue characterized by variability in both study design and patient outcomes.
The research, published in the journal Health and Quality of Life Outcomes and registered in PROSPERO, was motivated by the need to reconcile existing, often contradictory, evidence regarding the efficacy of carnitine in improving health-related quality of life. Investigators conducted an extensive search of online databases for relevant RCTs published up until November 9, 2025, applying no restrictions on language or publication date. The team employed a random-effect model to calculate the effect size of the interventions, utilizing Hedges’ g to interpret the extracted mean change values and standard deviations across the selected trials.
Quantitative analysis revealed that the most pronounced improvements were observed in general health, which yielded a Hedges’ g of 1.00 with a 95% confidence interval (CI) of 0.33 to 1.68. Significant positive effects were also documented for bodily pain, with a Hedges’ g of 0.83 (95% CI: 0.15, 1.50), and vitality, with a Hedges’ g of 0.81 (95% CI: 0.32, 1.30). Social functioning also demonstrated a clear improvement, showing a Hedges’ g of 0.72 (95% CI: 0.31, 1.13). In contrast, the meta-analysis found lower observed effects for emotional functioning and global quality of life, indicating that the benefits of the supplement may be domain-specific rather than a universal improvement in overall well-being.
A critical finding of the review was the absence of a statistically significant effect for other major dimensions of health. Specifically, the data indicated that carnitine supplementation did not produce significant improvements in mental health or physical functioning outcomes. This distinction underscores the multifaceted nature of quality of life, suggesting that while certain dimensions may be responsive to nutritional intervention, others may require different therapeutic approaches or interventions entirely.
The research team performed pre-planned subgroup analyses to explore the potential drivers of these varying results. They found that factors such as the specific target population, the geographic region of the studies, and the dosage, formulation, and duration of the carnitine intervention could possibly account for differences in the observed outcomes. Although sensitivity analyses were conducted and confirmed the overall robustness of the study findings, the researchers noted the presence of substantial residual heterogeneity across the included trials.
The study authors attributed this significant residual heterogeneity to the wide variability in measurement instruments utilized and the diverse designs adopted across the 20 RCTs. Consequently, while the findings support the potential for carnitine to enhance specific aspects of patient life, the researchers stressed the importance of caution in clinical application. They concluded that carnitine supplementation, especially when precisely tailored to the specific formulation and dose requirements of the patient, appears beneficial for bodily pain, general health, vitality, and social functioning.
Looking forward, the authors recommend that clinicians prioritize the individualization of supplementation strategies to optimize patient outcomes. Furthermore, the team highlights a clear need for future large-scale, well-designed randomized controlled trials that rigorously evaluate dose-response relationships, optimal intervention duration, and long-term clinical outcomes. Such research is considered essential to refine current clinical recommendations and provide more definitive guidance for practitioners and patients alike.
Subject of Research: Systematic review and meta-analysis of the effects of carnitine supplementation on various quality of life domains.
Article Title: Effect of carnitine supplementation on quality of life: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Article References: Honardoust, M., Ranjbar, R., Ahmadi, A., Foshati, S., & Mohsenpour, M. A. (2026). Effect of carnitine supplementation on quality of life: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Health and Quality of Life Outcomes. https://doi.org/10.1186/s12955-026-02643-4
Image Credits: AI Generated
DOI: 10.1186/s12955-026-02643-4
Keywords: Carnitine, Quality of Life, Systematic Review, Meta-analysis, Randomized Controlled Trials, General Health, Bodily Pain, Vitality, Social Functioning, Supplementation, Clinical Nutrition, Public Health, Health Outcomes, Nutrition Science, Metabolic Health
News Source: Daisy Hatcher. (November 19, 2026). Carnitine Supplementation May Improve General Health, Vitality, and Social Functioning. Scienmag.



